INS and Parkinson disease: GIGYF2 has been shown to play a role in the regulation of IGF-1R (insulin growth factor 1R) trafficking [64], suggesting insulin dysregulation as a disease-specific mechanism for both late-onset PD and cognitive dysfunction [62].